Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes

PB Rasmussen, S Bjørn, S Hastrup, PF Nielsen… - FEBS letters, 1996 - Elsevier
PB Rasmussen, S Bjørn, S Hastrup, PF Nielsen, K Norris, L Thim, FC Wiberg, H Flodgaard
FEBS letters, 1996Elsevier
Neutrophil-derived heparin-binding protein (HBP) is a strong chemoattractant for monocytes.
We report here for the first time the expression of recombinant HBP. A baculovirus
containing the human HBP cDNA mediated in insect cells the secretion of a 7-residue N-
terminally extended HBP form (pro-HBP). Deletion of the pro-peptide-encoding cDNA
sequence resulted in correctly processed HBP at the N-terminus. Electrospray mass
spectrum analysis of recombinant HBP yielded a molecular weight of 27.237±3 amu …
Neutrophil-derived heparin-binding protein (HBP) is a strong chemoattractant for monocytes. We report here for the first time the expression of recombinant HBP. A baculovirus containing the human HBP cDNA mediated in insect cells the secretion of a 7-residue N-terminally extended HBP form (pro-HBP). Deletion of the pro-peptide-encoding cDNA sequence resulted in correctly processed HBP at the N-terminus. Electrospray mass spectrum analysis of recombinant HBP yielded a molecular weight of 27.237 ± 3 amu. Consistent with this mass is a HBP form of 225 amino acids (mature part +3 amino acid C-terminal extension). The biological activity of recombinant HBP was confirmed by its chemotactic action towards monocytes. Furthermore, we have shown that recombinant HBP stimulates in a dose-dependent manner the lipopolysaccharide (LPS)-induced cytokine release from human monocytes.
Elsevier